Frazier Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Frazier Management’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-241,000	Closed	-$1.95M	–	44
2021 Q3	$1.95M	Hold	241,000	–	–	0.16%	39
2021 Q2	$2.37M	Hold	241,000	–	–	0.22%	33
2021 Q1	$2.13M	Hold	241,000	–	–	0.17%	34
2020 Q4	$2.46M	Buy	+241,000	New	+$2.64M	0.19%	31

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Frazier Management's GRTX Position: Q4 2021 in Review

Frazier Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 241,000 shares — an estimated $1.95M sold.

Frazier Management first reported a position in GRTX in Q4 2020 and held it in 4 quarters. The position peaked at $2.46M in Q4 2020. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

Frazier Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Frazier Management sold 241,000 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $1.95M.
Frazier Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Frazier Management's Galera Therapeutics, Inc. Common Stock position peaked at $2.46M in Q4 2020.
44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Frazier Management's 13F filing for Q4 2021, filed 8 Feb 2022.